Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Revance Therapeutics Inc (RVNC) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011463
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fasciitis among others. It also provides RT001, a topical gel formulation of daxibotulinumtoxinA, which is designed to eliminate the use of needles. Revance Therapeutics develops products for multiple aesthetic and therapeutic applications. The company utilizes TransMTS platform technology for the development of its products. It offers products for dermatology, neurology, musculoskeletal disorders, urology and ophthalmology. Revance Therapeutics is headquartered in Newark, California, the US.

Revance Therapeutics Inc (RVNC) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Revance Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Revance Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Secures US$40 Million In Venture Financing 13
ReVance Therapeutics Secures US$5 Million In Financing Round 14
Equity Offering 15
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 15
Revance Therapeutics Raises USD134.6 Public Offering of Shares 17
Revance Therapeutics Completes IPO For US$110.4 Million 19
Revance Therapeutics Inc – Key Competitors 21
Revance Therapeutics Inc – Key Employees 22
Revance Therapeutics Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 03, 2017: Revance Releases Second Quarter 2017 Results 24
May 09, 2017: Revance Releases First Quarter 2017 Results 25
Feb 27, 2017: Revance Releases Fourth Quarter and Full Year 2016 Results 26
Nov 03, 2016: Revance Releases Third Quarter 2016 Results 28
Aug 04, 2016: Revance Releases Second Quarter 2016 Results 29
May 09, 2016: Revance Releases First Quarter 2016 Results 30
Mar 02, 2016: Revance Releases Fourth Quarter and Full Year 2015 Results 31
Corporate Communications 32
Sep 06, 2017: Revance Appoints Mark Foley to its Board of Directors 32
Aug 02, 2017: Revance appoints new chief commercial officer and president of Aesthetics & Therapeutics 33
Jul 05, 2016: Revance Appoints Industry Leader Julian S. Gangolli to its Board of Directors 34
Mar 14, 2016: Revance Therapeutics Expands Leadership Team, Appoints Roman G. Rubio, MD, MBA, as Senior Vice President of Clinical Development 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Revance Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Revance Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Revance Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Revance Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Revance Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Revance Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Revance Therapeutics Raises US$10 Million In Venture Financing 10
Revance Therapeutics Raises US$56 Million In Extended Series E Financing 11
Revance Therapeutics Secures US$40 Million In Venture Financing 13
ReVance Therapeutics Secures US$5 Million In Financing Round 14
Revance Therapeutics Raises USD167.1 Million in Public Offering of Shares 15
Revance Therapeutics Raises USD134.6 Public Offering of Shares 17
Revance Therapeutics Completes IPO For US$110.4 Million 19
Revance Therapeutics Inc, Key Competitors 21
Revance Therapeutics Inc, Key Employees 22
Revance Therapeutics Inc, Subsidiaries 23

★海外企業調査レポート[Revance Therapeutics Inc (RVNC)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mediobanca – Banca di Credito Finanziario SpA (MB):企業の財務・戦略的SWOT分析
    Mediobanca - Banca di Credito Finanziario SpA (MB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Dechra Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Dechra Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dechra Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Spire, Inc.:企業の戦略・SWOT・財務情報
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Median Technologies SA (ALMDT):企業の財務・戦略的SWOT分析
    Summary Median Technologies SA (Median) is a medical technology company that develops and markets medical imaging solutions. The company offers clinical trials, imaging services for CT, scientific consulting, image and clinical data management, image data processing and site support, managed service …
  • Adecco Group AG:企業の戦略・SWOT・財務分析
    Adecco Group AG - Strategy, SWOT and Corporate Finance Report Summary Adecco Group AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Media General, Inc.:企業のM&A・事業提携・投資動向
    Media General, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Media General, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • IndiPharm Inc-製薬・医療分野:企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • Global Blood Therapeutics Inc (GBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Oneness Biotech Co Ltd (4743):製薬・医療:M&Aディール及び事業提携情報
    Summary Oneness Biotech Co Ltd (Oneness Biotech) is a biopharmaceutical company that conducts research and development of drugs. The company provides products such as anti acne products. Its technologies comprise GAP cultivation platform, medicinal material identification, and separation and purific …
  • S&C Electric Co:企業の戦略的SWOT分析
    S&C Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Midatech Pharma Plc (MTPH):企業の財務・戦略的SWOT分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The company’s products include gelclair, oravig, soltamox and zuplenz. It conducts research and development programs in the areas of oncology, autoimm …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Teradyne Inc (TER):企業の財務・戦略的SWOT分析
    Teradyne Inc (TER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aeolus Pharmaceuticals Inc (AOLS)-製薬・医療分野:企業M&A・提携分析
    Summary Aeolus Pharmaceuticals Inc (Aeolus) is a biopharmaceutical company that is developing a platform of new compounds for use in cancer, infectious diseases, central nervous system (CNS) diseases, fibrosis and biodefense. The company’s lead product, AEOL 10150 is a broad catalytic antioxidant pa …
  • Johnson & Johnson (JNJ):企業の財務・戦略的SWOT分析
    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Obsidian Energy Ltd (PWT)-石油・ガス分野:企業M&A・提携分析
    Summary Obsidian Energy Ltd (Obsidian) is formerly known as Penn West Petroleum Ltd it is a conventional oil and natural gas producer in Canada. It develops and explores oil and gas properties and related production infrastructure in the Western Canada Sedimentary Basin. Obsidian operates properties …
  • Technology Nexus AB:企業の戦略的SWOT分析
    Technology Nexus AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • XL Group Ltd:戦略・SWOT・企業財務分析
    XL Group Ltd - Strategy, SWOT and Corporate Finance Report Summary XL Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Kobayashi Pharmaceutical Co Ltd (4967):医療機器:M&Aディール及び事業提携情報
    Summary Kobayashi Pharmaceutical Co Ltd (Kobayashi) is a manufacturer and distributor of pharmaceutical, health and personal care products. The company offers OTC pharmaceuticals, oral hygiene products, deodorizing air fresheners, cooling gel sheets, sanitary products, household sundries, and body w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆